Tipping the balance: A biased nanobody antagonist of CCR3 with potential for the treatment of eosinophilic inflammation
- PMID: 30452926
- DOI: 10.1016/j.jaci.2018.10.052
Tipping the balance: A biased nanobody antagonist of CCR3 with potential for the treatment of eosinophilic inflammation
Keywords: Allergic inflammation; CCR3; asthma; biased antagonist; eosinophil; inflammation.
Comment on
-
Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness.J Allergy Clin Immunol. 2019 Feb;143(2):669-680.e12. doi: 10.1016/j.jaci.2018.05.003. Epub 2018 May 17. J Allergy Clin Immunol. 2019. PMID: 29778505 Free PMC article.
